First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer

Clinical trial NCT06521034 · COMPLETED

Trial details

NCT number: NCT06521034
Sponsor: Yongchang Zhang
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer EGFR Gene Mutation EGFR-TKI Sensitizing Mutation

Start date: 2019-06-27
Primary completion: 2021-05-17
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.